Effect of octreotide on total effective vascular compliance in patients with posthepatitic cirrhosis

Journal of Hepatology

Volumn 24, Issue 1, 1996, Pages 81-87

  Lin, Han Chieh ^b   Tsai, Yang Te ^a   Yang, May C M ^a   Lee, Fa Yauh ^a   Hou, Ming Chih ^a   Chen, Ling Sheng ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cirrhosis; Octreotide; Portal hypertension; Vascular compliance

Indexed keywords

OCTREOTIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELASTICITY; FEMALE; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VENOCONSTRICTION;

EID: 0030064947     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80190-5     Document Type: Article

References (39)

1. Vorobioff J, Brefeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244: G52-7.
2. Meng HC, Lin HC, Tsai YT, Lee FY, Liao DM, Hsia HC, Lin WJ, Chang TT, Lay CS, Wang SS, Lee SD, Lo KJ. Relationship between the severity of cirrhosis and hemodynamic values in patients with cirrhosis. J Gastroenterol Hepatol 1994; 9: 148-53.
3. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1998; 8: 1151-7.
4. Benoit JN, Granger DN. Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis 1986; 6: 287-98.
5. Ingles AC, Hernandez I, Garcia-Estañ J, Quesada T, Carbonell LF. Increased total vascular capacity in conscious cirrhotic rats. Gastroenterology 1992; 103: 275-81.
6. Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology 1992; 15: 809-15.
7. Guyton AC, Coleman TG, Granger HJ. Circulation: overall regulation. Am Rev Physiol 1972; 34: 13-46.
8. London GM, Levenson JA, London AM, Simon AC, Safar ME. Systemic compliance, renal hemodynamics and sodium excretion in hypertension. Kidney Int 1984; 26: 342-50.
9. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marback P, Petcher TJ, Pless J. SMS 201-995: a very potent and selective octapeptide analogue of sosmatostatin with prolonged action. Life Sci 1982; 31: 1133-40.
10. Hwang SJ, Lin HC, Chang CF, Lee FY, Lu CW, Hsia HC, Wang SS, Lee SD, Tsai YT, Lo KJ. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992; 16: 320-5.
11. Silvain C, Carpentier S, Sautereau D, Czernichow B, Métreau JM, Fort E, Ingrand P, Boyer J, Pillegand B, Doffël M, Dhumeaux D, Beauchant M. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 61-5.
12. Eriksson LS, Brundin T, Söderlund C, Wahren J. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987; 22: 919-25.
13. Pringle SD, McKee RF, Garden OJ, Lorimer AR, Carter DC. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis. Aliment Pharmacol Ther 1988; 2: 451-9.
14. McCormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, McIntyre N, Burroughs AK. Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990; 2: 489-92.
15. Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992; 103: 229-34.
16. McCormick PA, Biagini MR, Dick R, Greensladde L, Chin J, Cardin F, Wagstaff D, McIntyre N, Burroughs AK. Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension. A double-blind, placebo-controlled study. Hepatology 1992; 16: 1180-6.
17. Sieber CC, Mosca PG, Groszmann RJ. Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats. Am J Physiol 1992; 262: G274-7.
18. Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
19. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213-8.
20. Forrester JS, Ganz W, Diamond G, McHugh T, Chonette DW, Swan HJG. Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J 1972; 83: 306-11.
21. Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, Lee SD, Lo KJ. Comparison between portal vein pressure and wedge hepatic vein pressure in hepatitis-B related cirrhosis. J Hepatol 1989; 9: 326-30.
22. Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis. Hepatology 1989; 10: 283-7.
23. Echt M, Düweling J, Gauer OH, Lange L. Effective compliance of the total vascular bed and the intrathoracic compartment derived from changes in central venous pressure induced by volume changes in man. Circ Res 1974; 34: 61-8.
24. London GM, Safar ME, Simon AC, Alexandre JM, Levenson JA, Weiss YA. Total effective compliance, cardiac output and fluid volumes in essential hypertension. Circulation 1978; 57: 995-1000.
25. Rothe CF. Reflex control of veins and vascular capacitance. Physiol Rev 1983; 63: 1281-342.
26. Greenway CV, Seaman KL, Innes IR. Norepinephrine on venous compliance and unstressed volume in cat liver. Am J Physiol 1985; 248: H468-H476.
27. Lautt WW, Greenway CV, Legare DJ. Index of contractility: quantitative analysis of hepatic venous distensibility. Am J Physiol 1991; 260: G325-32.
28. Gentilini P, Laffi G, Fantini F, Donato M, Dabizzi PR, La Villa G, Pinzani M. Systemic hemodynamic and renal function in cirrhotic patients during plasma volume expansion. Digestion 1983; 27: 138-45.
29. Tristani FE, Cohn JN. Systemic and renal hemodynamic in oliguric hepatic failure: effect of volume expansion. J Clin Invest 1967; 46: 1894-906.
30. Kroeger RJ, Groszmann RJ. Increased portal venous resitance hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive model. Hepatology 1985; 5: 97-101.
31. Pizcueta MP, García-Pagán JC, Fernández M, Casamitjana R, Bosch J, Rodés J. Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. Gastroenterology 1991; 101: 1710-5.
32. Benoit JN, Zimmerman B, Premen AJ, Go W, Granger DN. Role of glucagon in the splanchnic hyperemia of chronic portal hypertension. Am J Physiol 1986; 251: G674-7.
33. Pizcueta MP, Casamiyjana R, Bosch J, Rodés J. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. Am J Physiol 1990; 258: G191-5.
34. Mesh CL, Joh T, Korthuis RJ, Granger DN, Benoit JN. Intestinal vascular sensitivity to vasopressin in portal hypertensive rats. Gastroenterology 1991; 100: 916-21.
35. Sieber CC, Lee FY, Groszmann RJ. Chronic octreotide treatment prevents the in vitro vascular hyporeactivity in portal hypertensive rats (Abstract). Hepatology 1994; 19: 1241.
36. 1-adrenoceptors of portal hypertensive rats. Br J Pharmacol 1994; 111: 439-44.
37. Flavahan NA, Rimele TJ, Cooke JP, Vanhoutte PM. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther 1984; 230: 699-705.
38. 2- like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 1981; 48: 875-84.
39. Lautt WW, Schafer J, Legare DJ. Effect of adenosine and glucagon on hepatic volume responses to sympathetic nerve. Can J Physiol Pharmacol 1991; 69: 43-8.